Nathaniel M. Lewis

机构：Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention · ORCID：0000-0001-7088-9640

发表论文 136 篇 · 总被引 4291 次 · h-index 37

代表论文

• Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025 (2025 · MMWR Morbidity and Mortality Weekly Report · 被引 87)
• RSV Vaccine Effectiveness Against Hospitalization Among US Adults 60 Years and Older (2024 · JAMA · 被引 68)
• Interim Estimates of 2024–2025 Seasonal Influenza Vaccine Effectiveness — Four Vaccine Effectiveness Networks, United States, October 2024–February 2025 (2025 · MMWR Morbidity and Mortality Weekly Report · 被引 63)
• Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity—IVY Network, 26 Hospitals, 18 October 2023–9 March 2024 (2024 · Clinical Infectious Diseases · 被引 45)
• RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons (2025 · JAMA · 被引 30)
• Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study (2024 · Clinical Infectious Diseases · 被引 12)